On September 20, Simcere Pharma (02096) spent 3.7869 million Hong Kong dollars to repurchase 610,000 shares.
Sinopharm Group Co., Ltd. (02096) announced that the company invested 3.7869 million Hong Kong dollars on September 20, 2024...
SIMCERE PHARMA (02096) announced that the company repurchased 610,000 shares for a total of HK$3.769 million on September 20, 2024, at a repurchase price range of HK$6.17 to HK$6.25 per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
